Sampsonas Fotios, Karamouzos Vasileios, Karampitsakos Theodoros, Papaioannou Ourania, Katsaras Matthaios, Lagadinou Maria, Zarkadi Eirini, Malakounidou Elli, Velissaris Dimitrios, Stratakos Grigorios, Tzouvelekis Argyrios
Respiratory Medicine Department, University Hospital of Patras, Patras, Greece.
Intensive Care Unit, University Hospital of Patras, Patras, Greece.
Front Med (Lausanne). 2022 Feb 24;9:815799. doi: 10.3389/fmed.2022.815799. eCollection 2022.
High-flow nasal cannula (HFNC) oxygenation method has been proven to be successful in oxygenation of patients with respiratory failure and has exhibited clinical superiority compared to low-flow nasal cannula (LFNC).
We performed a systematic review and meta-analysis to evaluate the potential favorable impact of HFNC oxygenation during bronchoscopy and related procedures like endobronchial ultrasound-transbronchial needle aspiration. Only randomized control trials (RCTs) were included in the meta-analysis.
Six randomized control trials with 1,170 patients were included in this meta-analysis. Patients who underwent bronchoscopy with the use of high-flow nasal cannula experienced less hypoxemic events/desaturations, less procedural interruptions and pneumothoraxes compared to patients under low-flow nasal cannula treatment. This beneficial effect of HFNC in hypoxemic events was persistent 10 min after the end of procedure.
The high-flow nasal cannula (HFNC) oxygenation method could reduce hypoxemic events and related peri- and post-bronchoscopic complications.
高流量鼻导管(HFNC)氧疗方法已被证明在呼吸衰竭患者的氧疗中取得成功,并且与低流量鼻导管(LFNC)相比已显示出临床优势。
我们进行了一项系统评价和荟萃分析,以评估在支气管镜检查及诸如支气管内超声引导下经支气管针吸活检等相关操作期间HFNC氧疗的潜在有利影响。荟萃分析仅纳入随机对照试验(RCT)。
该荟萃分析纳入了6项随机对照试验,共1170例患者。与接受低流量鼻导管治疗的患者相比,使用高流量鼻导管进行支气管镜检查的患者发生低氧血症事件/血氧饱和度下降的情况更少,操作中断和气胸也更少。HFNC对低氧血症事件的这种有益作用在操作结束后10分钟仍持续存在。
高流量鼻导管(HFNC)氧疗方法可减少低氧血症事件以及支气管镜检查期间及术后的相关并发症。